| Literature DB >> 35635565 |
Eladio Dominguez-Antuña1, José Carlos Diz2,3, David Suárez-Iglesias4, Carlos Ayán3.
Abstract
INTRODUCTION AND HYPOTHESIS: Studies on the prevalence of urinary incontinence (UI) among CrossFit practitioners are on the rise. This systematic review with meta-analysis was aimed at determining the prevalence of UI among CrossFit practitioners.Entities:
Keywords: Fitness; High-intensity functional training; Pelvic floor; Stress incontinence; Women's health
Year: 2022 PMID: 35635565 PMCID: PMC9150382 DOI: 10.1007/s00192-022-05244-z
Source DB: PubMed Journal: Int Urogynecol J ISSN: 0937-3462 Impact factor: 1.932
Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) 2020 27-item checklist
| Section and topic | Item # | Checklist item | Page/document |
|---|---|---|---|
| Title | |||
| Title | 1 | Identify the report as a systematic review | Title page |
| Abstract | |||
| Abstract | 2 | See the PRISMA 2020 for Abstracts checklist | 1–2 |
| Introduction | |||
| Rationale | 3 | Describe the rationale for the review in the context of existing knowledge | 3–4 |
| Objectives | 4 | Provide an explicit statement of the objective(s) or question(s) the review addresses | 4 |
| Methods | |||
| Eligibility criteria | 5 | Specify the inclusion and exclusion criteria for the review and how studies were grouped for the syntheses | 4–5 |
| Information sources | 6 | Specify all databases, registers, websites, organisations, reference lists and other sources searched or consulted to identify studies. Specify the date when each source was last searched or consulted | 26 |
| Search strategy | 7 | Present the full search strategies for all databases, registers and websites, including any filters and limits used | 4, Appendix |
| Selection process | 8 | Specify the methods used to decide whether a study met the inclusion criteria of the review, including how many reviewers screened each record and each report retrieved, whether they worked independently, and if applicable, details of automation tools used in the process | 5 |
| Data collection process | 9 | Specify the methods used to collect data from reports, including how many reviewers collected data from each report, whether they worked independently, any processes for obtaining or confirming data from study investigators, and if applicable, details of automation tools used in the process | 5 |
| Data items | 10a | List and define all outcomes for which data were sought. Specify whether all results that were compatible with each outcome domain in each study were sought (e.g. for all measures, time points, analyses), and if not, the methods used to decide which results to collect | 5 |
| 10b | List and define all other variables for which data were sought (e.g. participant and intervention characteristics, funding sources). Describe any assumptions made about any missing or unclear information | 5 | |
| Study risk of bias assessment | 11 | Specify the methods used to assess risk of bias in the studies included, including details of the tool(s) used, how many reviewers assessed each study and whether they worked independently, and if applicable, details of automation tools used in the process | 5 |
| Effect measures | 12 | Specify for each outcome the effect measure(s) (e.g. risk ratio, mean difference) used in the synthesis or presentation of results | 5–6 |
| Synthesis methods | 13a | Describe the processes used to decide which studies were eligible for each synthesis (e.g. tabulating the study intervention characteristics and comparing against the planned groups for each synthesis (item #5)) | NR |
| 13b | Describe any methods required to prepare the data for presentation or synthesis, such as handling of missing summary statistics, or data conversions | NR | |
| 13c | Describe any methods used to tabulate or visually display results of individual studies and syntheses | NR | |
| 13d | Describe any methods used to synthesise results and provide a rationale for the choice(s). If meta-analysis was performed, describe the model(s), method(s) used to identify the presence and extent of statistical heterogeneity, and the software package(s) used | 5–6 | |
| 13e | Describe any methods used to explore possible causes of heterogeneity among study results (e.g. subgroup analysis, meta-regression) | 6 | |
| 13f | Describe any sensitivity analyses conducted to assess the robustness of the synthesised results | NR | |
| Reporting bias assessment | 14 | Describe any methods used to assess risk of bias due to missing results in a synthesis (arising from reporting biases) | NR |
| Certainty assessment | 15 | Describe any methods used to assess certainty (or confidence) in the body of evidence for an outcome | NR |
| Results | |||
| Study selection | 16a | Describe the results of the search and selection process, from the number of records identified in the search to the number of studies included in the review, ideally using a flow diagram | 6, Fig. |
| 16b | Cite studies that might appear to meet the inclusion criteria, but which were excluded, and explain why they were excluded | 6 | |
| Study characteristics | 17 | Cite each study included and present its characteristics | 6, Table |
| Risk of bias in studies | 18 | Present assessments of risk of bias for each study included | 7, Table |
| Results of individual studies | 19 | For all outcomes, present, for each study: (a) summary statistics for each group (where appropriate) and (b) an effect estimate and its precision (e.g. confidence/credible interval), ideally using structured tables or plots | Table |
| Results of syntheses | 20a | For each synthesis, briefly summarise the characteristics and risk of bias among contributing studies | 8 |
| 20b | Present results of all statistical syntheses conducted. If meta-analysis was done, present for each the summary estimate and its precision (e.g. confidence/credible interval) and measures of statistical heterogeneity. If comparing groups, describe the direction of the effect | 8, Fig. | |
| 20c | Present results of all investigations of possible causes of heterogeneity among study results | NR | |
| 20d | Present results of all sensitivity analyses conducted to assess the robustness of the synthesised results | NR | |
| Reporting biases | 21 | Present assessments of risk of bias due to missing results (arising from reporting biases) for each synthesis assessed | NR |
| Certainty of evidence | 22 | Present assessments of certainty (or confidence) in the body of evidence for each outcome assessed | NR |
| Discussion | |||
| Discussion | 23a | Provide a general interpretation of the results in the context of other evidence | 10–12 |
| 23b | Discuss any limitations of the evidence included in the review | 12 | |
| 23c | Discuss any limitations of the review processes used | 12 | |
| 23d | Discuss the implications of the results for practice, policy and future research | 10–12 | |
| Other information | |||
| Registration and protocol | 24a | Provide registration information for the review, including register name and registration number, or state that the review was not registered | 4 |
| 24b | Indicate where the review protocol can be accessed, or state that a protocol was not prepared | 4 | |
| 24c | Describe and explain any amendments to information provided at registration or in the protocol | NR | |
| Support | 25 | Describe sources of financial or non-financial support for the review, and the role of the funders or sponsors in the review | 13 |
| Competing interests | 26 | Declare any competing interests of review authors | 13 |
| Availability of data, code and other materials | 27 | Report which of the following are publicly available and where they can be found: template data collection forms; data extracted from the studies included; data used for all analyses; analytic code; any other materials used in the review | 13 |
From: Page et al. [15]. For more information, visit: http://www.prisma-statement.org
NR not reported
Fig. 1Flow diagram of the search and selection process for the inclusion of articles
Methodological quality assessment
| Reference | OCEBM level of evidence | Study design | Sample size calculation | Sources of bias |
|---|---|---|---|---|
| Comparative studies | ||||
| Elks et al. [ | 4 | Cross-sectional | Yes | Selection bias (i.e. voluntary response); unequal group size; self-reported data; exercise intensity was not controlled; inability to assess the survey participation rate |
| Forner et al. [ | 4 | Cross-sectional | No | Selection bias (i.e. voluntary response); unequal group size; self-reported data; lack of questions about urine leakage during CF exercises; inability to assess the survey participation rate |
| Khowailed et al. [ | 4 | Cross-sectional | No | Selection bias (i.e. voluntary response); small sample size; self-reported data; multigravida women were not adequately controlled; inability to assess the survey participation rate |
| De Machado et al. [ | 4 | Cross-sectional | Yes | Selection bias (i.e. only nulliparous women aged between 18 and 35 years with a body mass index ≤ 30 kg/m2 were included; the folder disclosure was carried in a single institution of higher education); small sample size; sample size calculation based on a measure not used in the study; self-reported data; the recruitment rate was not assessed |
| Middlekauff et al.[ | 4 | Cross-sectional | Yes | Selection bias (i.e. only nulliparous women aged between 18 and 35 years were included); self-reported data; the recruitment rate was not assessed |
| Yang et al. [ | 4 | Cross-sectional | No | Selection bias (i.e. regional sample; voluntary response; some women did not participate in specific exercises); small sample size; unequal group size; self-reported data; the recruitment rate was not assessed |
| Non-comparative studies | ||||
| Poli De Araújo et al. [ | 4 | Cross-sectional | Yes | Selection bias (i.e. voluntary response; heterogeneity of CF training experience); questionnaire not validated; self-reported data; inability to assess the survey participation rate |
| Dias et al. [ | 4 | Cross-sectional | No | Selection bias (i.e. recruitment from a single CF centre; voluntary response; included women with only 1 month of CF practice); small sample size; the recruitment rate was not assessed |
| High et al. [ | 4 | Cross-sectional | No | Selection bias (i.e. voluntary response); self-reported data; inability to assess the survey participation rate |
| Lopes et al. [ | 4 | Cross-sectional | No | Selection bias (i.e. recruitment from only two CF centres; only women aged between 18 and 35 years were included; voluntary response; the majority of the sample had less than 1 year of experience in CF training); small sample size; self-reported data; the recruitment rate was not assessed |
| Pisani et al. [ | 4 | Cross-sectional | No | Selection bias (i.e. voluntary response); self-reported data; inability to assess the survey participation rate |
| Pisani et al. [ | 4 | Cross-sectional | No | Selection bias (i.e. voluntary response); self-reported data; inability to assess the survey participation rate |
| Wikander et al. [ | 4 | Cross-sectional | No | Selection bias (i.e. competitive women CF participants were included; voluntary response); self-reported data; inability to assess the survey participation rate |
Abbreviations: CF CrossFit, OCEBM Oxford Centre of Evidence-Based Medicine, UI urinary incontinence
Newcastle–Ottawa Scale, adapted for quality assessment of cross-sectional studies
| Reference | Selection (maximum 5 stars) | Comparability (maximum 2 stars)a | Outcome (maximum 3 stars) | Quality rating (maximum 10 stars)b | ||||
|---|---|---|---|---|---|---|---|---|
| Representativeness of the sample (☆) | Sample size (☆) | Non-respondents (☆) | Ascertainment of the exposure (☆☆) | Based on design and analysis (☆☆) | Assessment of the outcome (☆☆) | Statistical test (☆) | ||
| Elks et al. [ | ☆ | ☆ | ☆ | ☆☆ | ☆ | Poor (6/10 stars) | ||
| Forner et al. [ | ☆ | ☆ | ☆ | Poor (3/10 stars) | ||||
| Khowailed et al. [ | ☆ | ☆ | Poor (2/10 stars) | |||||
| De Machado et al. [ | ☆ | ☆ | ☆ | Poor (3/10 stars) | ||||
| Middlekauff et al.[ | ☆ | ☆ | ☆ | ☆ | Poor (4/10 stars) | |||
| Yang et al. [ | ☆ | ☆☆ | ☆ | ☆ | Poor (5/10 stars) | |||
| Poli De Araújo et al. [ | ☆ | ☆ | ☆ | ☆☆ | ☆ | ☆ | Fair (7/10 stars) | |
| Dias et al. [ | ☆ | ☆ | Poor (2/10 stars) | |||||
| High et al. [ | ☆ | ☆ | ☆☆ | ☆ | ☆ | Poor (6/10 stars) | ||
| Lopes et al. [ | ☆ | ☆ | ☆ | Poor (3/10 stars) | ||||
| Pisani et al. [ | ☆ | ☆ | ☆ | ☆☆ | ☆ | ☆ | Fair (7/10 stars) | |
| Pisani et al. [ | ☆ | ☆ | ☆ | ☆☆ | ☆ | ☆ | Fair (7/10 stars) | |
| Wikander et al. [ | ☆ | ☆ | Poor (2/10 stars) | |||||
Abbreviations: max, maximum aOne ☆ was allocated if the study adjusted for age, with an additional ☆ given if adjusted for parity or body mass index
bScores were allocated for urinary incontinence outcomes. Good quality: 4–5 stars in the selection domain, 1–2 stars in the comparability domain, and 2–3 stars in the outcome domain. Fair quality: 3 stars in the selection domain, 1–2 stars in the comparability domain and 2–3 stars in the outcome domain. Poor quality: 1–2 stars in the selection domain or 0 stars in the comparability domain or 0–1 star(s) in the outcome domain
Comparative studies assessing urinary incontinence (UI) among female CrossFit practitioners (CFG) and control participants (CG)
| Reference, country and sample | Variables (tools) | Participants with UI, severity and type | Factors associated with UI | Comparative results CFG-CG |
|---|---|---|---|---|
| Elks et al. [ | ||||
| 423 women (mean age; range): | Prevalence: | Women with UI ( | Multiparity | Prevalence (proportion of each group; |
| CFG: | UDI-6 | CFG: 256 | Vaginal delivery | UI: CFG 84% vs CG 48%; |
| CG: | POPDI-6 | Severity ( | Postmenopausal status | Severity (proportion of each group; |
| Parity ( | Severity: | Slight: 133 | Body mass index | Slight: CFG 44% vs CG 34%; |
| CFG: 3 | ISI | Moderate: 116 | Pelvic surgery | Moderate: CFG 38% vs CG 14%; |
| CG: 3 | Type: | Severe: 7 | CF exercises ( | Severe: CFG 2% vs CG 0%; |
| CF experience: NR | Specific items | Type ( | Jump rope DU: 166; 65% | Type (proportion of each group; |
| Competitive status: NR | SUI: 186 | SUI: CFG 73% vs CG 47%; | ||
| UUI: 140 | UUI: CFG 55% vs CG 42%; | |||
| MUI: 128 | MUI: CFG 50% vs CG 31%; | |||
| Forner et al. [ | ||||
| 1,379 women (mean age ± SD): | Prevalence: | Women with UI: NR | Parity | Prevalence (proportion of each group): |
| CFG: | UDI-6 | Severity: NR | UI: CFG 50.4 % vs CG 51.6 % | |
| CG: | CRADI-8 | Type ( | Severity: NR | |
| Parity ( | POPDI-6 | SUI: 355 | Type (proportion of each group; | |
| CFG: 433 | Severity: NR | UUI: 208 | SUI: | |
| CG: 295 | Type: | MUI: 410 | Parous: CFG 51.5% vs CG 8.1%; | |
| CF experience: NR | UDI-6 | Nulliparous: CFG 30% vs CG 23.9 %; | ||
| Competitive status: NR | UUI: | |||
| Parous: CFG 29% vs CG 36.3%; | ||||
| Nulliparous: CFG 19% vs CG 21.7%; | ||||
| MUI: | ||||
| Parous: CFG 57.3% vs CG 57.3%; | ||||
| Nulliparous: CFG 37.2% vs CG 34.5%; | ||||
| Khowailed et al. [ | ||||
| 14 women (mean age; range) | Prevalence: | Women with UI ( | Parity | Prevalence (proportion of each group; |
| CFG: | Carls’ UI survey | CFG: 6 | CF exercises ( | CFG > CG; |
| CG: | Severity: NR | CG: 2 | Jumps: 7; 77.8% | Severity: NR |
| Parity ( | Type: NR | Severity: NR | Running: 6; 66.7% | Type: NR |
| CF experience: NR | Type: NR | Lifting: 3; 33.3% | ||
| Competitive status: NR | ||||
| De Machado et al. [ | ||||
| 41 women (mean age ± SD) | Prevalence: | Women with UI ( | CF exercises ( | Prevalence (proportion of each group; |
| CFG: | ICIQ-SF | CFG: 12 | Jumps: NR | UI: CFG 60% vs CG 9.5%; |
| CG: | Severity: | Severity ( | Lifting: NR | Severity (proportion of each group): |
| Parity ( | ICIQ-SF | Mild: 2 | Mild: CFG 9.5% vs CG 0% | |
| CF experience (mean; range): | Type: NR | Moderate: 10 | Moderate: CFG 50% vs CG 9.5% | |
| 22; 6–60 months | Severe: 0 | Severe: 0 | ||
| Competitive status ( | Very severe: 0 | Very severe: 0 | ||
| CFG = 12 | Type: NR | Type: NR | ||
| Middlekauff et al.[ | ||||
| 70 women (mean age ± SD) | Prevalence: | Women with UI ( | No statistically significant associations were found | Prevalence (proportion of each group): |
| CFG: | EPIQ and POP-Q | CFG: 9 | UI: CFG 27.7% vs CG 8.5% | |
| CG: | Severity: NR | Severity: NR | Severity: NR | |
| Parity ( | Type: NR | Type: NR | Type: NR | |
| CF experience (mean ± SD): | ||||
| 22.1 ± 12.3 months | ||||
| Competitive status: NR | ||||
| Yang et al. [ | ||||
| 149 women (mean age): | Prevalence: | Women with UI ( | Parity | Prevalence (proportion of each group): |
| CFG: | ISSI | CFG: 53 | Vaginal delivery | UI: CFG 55.6% vs CG 31.8% |
| CG: | Severity: | Severity ( | CF exercises ( | Severity: NR |
| Parity ( | ISSI | Mild: 34 | Jump rope DU: 50; 94.3% | Type: NR |
| CFG: 67 | Type: NR | Moderate to severe: 19 | Jump rope SU: 43; 81.1% | |
| CF experience: NR | Type: NR | Box jump: 30; 56.6% | ||
| Competitive status: NR | ||||
Abbreviations: CF CrossFit, CRADI-8 Colorectal–Anal Distress Inventory-8, DU double unders, EPIQ Epidemiology of Prolapse and Incontinence Questionnaire, ISI Incontinence Severity Index, ISSI Incontinence Symptom Severity Index, MUI mixed urinary incontinence, NR not reported, POPDI-6 Pelvic Organ Prolapse Distress Inventory-6, POP-Q Pelvic Organ Prolapse Quantifications System, SU single unders, SUI stress urinary incontinence, UDI-6 Urinary Distress Inventory-6, UUI urgency urinary incontinence
Non-comparative studies assessing urinary incontinence (UI) among female CrossFit practitioners
| Reference, country and sample | Variables (tools) | Participants with UI, severity and type | Risk factors |
|---|---|---|---|
| Poli De Araújo et al. [ | |||
| 551 women | Prevalence: NR | Women with UI ( | Age |
| Mean age ± SD; range: 31.8 ± 7.4; 16–64 years | Severity: NR | Severity: NR | CF exercises ( |
| Parity ( | Type: NR | Type: NR | Jump rope DU: 111; 67.3% |
| CF experience of parous women ( | Jump rope SU: 44; 26.7% | ||
| < 6 months: 38 | |||
| 7–23 months: 20 | |||
| 24+ months: 117 | |||
| Competitive status: NR | |||
| Dias et al. [ | |||
| 34 women | Prevalence: | Women with UI ( | Multiparity |
| Mean age ± SD: 30.3 ± 6.4 years | Questionnaire by researchers | Severity: NR | Vaginal delivery |
| Parity ( | Severity: NR | Type ( | CF training frequency |
| CF experience ( | Type: | UUI: 3 | |
| < 6 months: 8 | Questionnaire by researchers | ||
| 7–23 months: 20 | |||
| 24+ months: 6 | |||
| Competitive status: NR | |||
| High et al. [ | |||
| 314 women | Prevalence: | Women with UI ( | Parity |
| Mean age ± SD; range: 36 ± 10; 20–71 years | PFDI-20 | Severity: NR | Vaginal delivery |
| Parity ( | IIQ | Type ( | Age |
| CF experience (mean ± SD): 46 ± 30 months | ICIQ-SF | SUI: 49 | |
| Competitive status: NR | Severity: NR | UUI: 42 | |
| Type: ICIQ-SF | |||
| Lopes et al. [ | |||
| 50 women | Prevalence: | Women with UI ( | No statistically significant associations were found |
| Mean age ± SD; range: 28.6 ± 4.5; 18–35 years | ICIQ-SF | Severity: NR | |
| Parity ( | Severity: NR | Type ( | |
| CF experience ( | Type: | SUI: 8 | |
| < 12 months: 29 | ICIQ-SF | UUI: 1 | |
| 12–24 months: 9 | MUI: 1 | ||
| 24+ months: 12 | |||
| Competitive status: NR | |||
| Pisani et al. [ | |||
| 828 women | Prevalence: | Women with UI ( | Gestation |
| Mean age ± SD: 31.4 ± 7.6 years | ICIQ-SF | Severity of urine loss amount ( | Multigravida |
| Parity ( | Severity: NR | Small: 268 | History of: |
| CF experience ( | Type: | Moderate: 25 | Sexual dysfunction |
| < 6 months: 37 | ICIQ-SF | Large: 5 | Pelvic organ prolapses |
| 6–12 months: 60 | Type ( | Vaginismus | |
| 12–24 months: 115 | SUI: 263 | Dyspareunia | |
| 24+ months: 86 | UUI: 16 | ||
| Competitive status: NR | MUI: 19 | ||
| Pisani et al. [ | |||
| 828 women | Prevalence: | Women with UI ( | Vaginal delivery: ×2.1 risk |
| Mean age ± SD: 30.6 ± 6.6 years | ICIQ-SF | Severity: NR | CF training frequency >5/week: ×3 risk |
| Parity ( | Severity: NR | Type ( | CF exercises ( |
| CF experience ( | Type: | SUI: 263 | Jump rope DU: 152; 51.0% |
| < 6 months: 98 | ICIQ-SF | UUI: 16 | Jump rope SU: 100; 33.6% |
| 6–12 months: 173 | MUI: 19 | Box jump: 63; 21.1% | |
| 12–24 months: 313 | Running: 38; 12.8% | ||
| 24+ months: 244 | Front squat: 30; 10.0% | ||
| Competitive status ( | |||
| 0 participations/year: 499 | |||
| 1 participations/year: 174 | |||
| 2 participations/year: 101 | |||
| >2 participations/year: 54 | |||
| Wikander et al. [ | |||
| 452 women | Prevalence: NR | Women with UI ( | Multiparity |
| Mean age ± SD; range: 36 ± 9; 20–63 years | Severity: | Severity ( | Exercises ( |
| Parity: NR | ISI | Slight: 89 | Jump rope SU: 177; 85.1% |
| CF experience: | Type: NR | Moderate: 83 | Jump rope DU: 167; 80.8% |
| Type 1 ( | Severe: 6 | Running: 93; 44.7% | |
| Type 2 ( | Very severe: 5 | Box jump: 85; 40.9% | |
| Competitive status: NR | Type: NR | Deadlift: 62; 29.8% | |
| Previous UI ( | Back squat: 57; 27.4% | ||
| Front squat: 54; 26.0% | |||
Abbreviations: CF CrossFit, DU double unders, ICIQ-SF International Consultation on Incontinence Questionnaire Short-Form, ISI Incontinence Severity Index, IIQ Incontinence Impact Questionnaire, MUI mixed urinary incontinence, NR not reported, PFDI-20 Pelvic Floor Distress Inventory Short Form-20, SU single unders, SUI stress urinary incontinence, UUI urgency urinary incontinence
aUI prior to CF practice, during daily activities but not during training or competitions
bUI prior to CF practice, not during daily activities but during training
cThe total number of participants reporting the severity of their UI (n = 183) differs from the total number of participants reporting UI (n = 208)
Fig. 2Total prevalence of urinary incontinence among CrossFit practitioners